LENZ Therapeutics, Inc. (LENZ)Healthcare | Biotechnology | Solana Beach, United States | NasdaqGS
10.26 USD
+0.13
(1.283%)
⇧
(April 21, 2026, 12:11 p.m.
EDT)
Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 10:34 p.m. EDT
LENZ is a fundamental value trap with severe cash burn (-40M FCF) and negative earnings, rendering it unsuitable for long-term holding despite a bullish consensus based on local biotech hype. The recent price recovery (from $8.25 lows to $10.18) is likely temporary dry powder, but the negative 18% forecasted return and crashing analyst price targets suggest the odds are currently stacked heavily against the shares unless a specific clinical binary event occurs immediately. Avoid the dividend signals as they are likely backend accounting artifacts given the massive burn; this is a speculative lemma play, not an investment. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.493793 |
| AutoETS | 0.502187 |
| MSTL | 0.507541 |
| AutoTheta | 0.534275 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 49% |
| H-stat | 4.62 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.656 |
| Excess Kurtosis | -0.53 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Last Dividend Date | 2024-03-21 |
| Debt to Equity Ratio | 0.287 |
| Revenue per Share | 0.662 |
| Market Cap | 321,696,096 |
| Forward P/E | -3.89 |
| Beta | 2.30 |
| Website | https://www.lenz-tx.com |
As of April 18, 2026, 10:34 p.m. EDT: Options flow reveals a hedged but slightly cautious sentiment. In the near term (April 17 call expiration), Put Open Interest (1.4k) exceeds Call OI (1.4k), suggesting defensive positioning. However, significant 'Top OI' for both Calls and Puts are clustered at strikes far out of the money (30-45 for calls, 17.5 for puts), indicating speculation on a massive volatility event rather than directional movement. The adjusted IV in expirations through May 15 suggests a premium discount, but the massive downside skew in long-dated puts (Jan 2027) implies a deep fear of a crash, while analyst targets suggest a potential upside gap. The speculators are positioned for a binary move rather than a steady drift.
| Date | Dividend | Yield % |
|---|---|---|
| 2024-03-22 | 7.21 | 44.506171 |
| 2024-03-15 | 7.21 | 45.612034 |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.60721207 |
| Address1 | 201 Lomas Santa Fe Drive |
| Address2 | Suite 300 |
| All Time High | 238.0 |
| All Time Low | 8.25 |
| Ask | 12.82 |
| Ask Size | 2 |
| Audit Risk | 6 |
| Average Daily Volume10 Day | 661,200 |
| Average Daily Volume3 Month | 990,916 |
| Average Volume | 990,916 |
| Average Volume10Days | 661,200 |
| Beta | 2.295 |
| Bid | 7.46 |
| Bid Size | 2 |
| Board Risk | 7 |
| Book Value | 9.071 |
| City | Solana Beach |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 10.26 |
| Current Ratio | 14.226 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 10.39 |
| Day Low | 9.94 |
| Debt To Equity | 0.287 |
| Display Name | LENZ Therapeutics |
| Dividend Date | 1,710,979,200 |
| Earnings Call Timestamp End | 1,774,355,400 |
| Earnings Call Timestamp Start | 1,774,355,400 |
| Earnings Timestamp | 1,774,355,400 |
| Earnings Timestamp End | 1,778,070,600 |
| Earnings Timestamp Start | 1,778,070,600 |
| Ebitda | -90,851,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.287 |
| Enterprise To Revenue | 1.367 |
| Enterprise Value | 26,088,012 |
| Eps Current Year | -3.79153 |
| Eps Forward | -2.63444 |
| Eps Trailing Twelve Months | -2.85 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 11.3282 |
| Fifty Day Average Change | -1.0682001 |
| Fifty Day Average Change Percent | -0.09429566 |
| Fifty Two Week Change Percent | -60.721207 |
| Fifty Two Week High | 50.4 |
| Fifty Two Week High Change | -40.14 |
| Fifty Two Week High Change Percent | -0.79642856 |
| Fifty Two Week Low | 8.25 |
| Fifty Two Week Low Change | 2.0100002 |
| Fifty Two Week Low Change Percent | 0.24363638 |
| Fifty Two Week Range | 8.25 - 50.4 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,624,627,800,000 |
| Float Shares | 18,482,161 |
| Forward Eps | -2.63444 |
| Forward P E | -3.894566 |
| Free Cashflow | -40,249,248 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 152 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.9781 |
| Gross Profits | 18,670,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.02651 |
| Held Percent Institutions | 1.19223 |
| Implied Shares Outstanding | 31,354,394 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Dividend Date | 1,711,065,600 |
| Last Dividend Value | 7.21 |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,711,065,600 |
| Last Split Factor | 1:7 |
| Long Business Summary | LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California. |
| Long Name | LENZ Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 321,696,096 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_370131860 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -82,127,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 317,933,555 |
| Number Of Analyst Opinions | 7 |
| Open | 10.12 |
| Operating Cashflow | -69,170,000 |
| Operating Margins | -24.221031 |
| Overall Risk | 8 |
| Payout Ratio | 0.0 |
| Phone | 858 925 7000 |
| Previous Close | 10.13 |
| Price Eps Current Year | -2.7060318 |
| Price Hint | 2 |
| Price To Book | 1.131077 |
| Price To Sales Trailing12 Months | 16.853315 |
| Profit Margins | 0.0 |
| Quick Ratio | 13.913 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.13000011 |
| Regular Market Change Percent | 1.283318 |
| Regular Market Day High | 10.39 |
| Regular Market Day Low | 9.94 |
| Regular Market Day Range | 9.94 - 10.39 |
| Regular Market Open | 10.12 |
| Regular Market Previous Close | 10.13 |
| Regular Market Price | 10.26 |
| Regular Market Time | 1,776,787,919 |
| Regular Market Volume | 120,064 |
| Return On Assets | -0.21858999 |
| Return On Equity | -0.33629 |
| Revenue Per Share | 0.662 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 31,354,394 |
| Shares Percent Shares Out | 0.2881 |
| Shares Short | 9,033,400 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 8,901,283 |
| Short Name | LENZ Therapeutics, Inc. |
| Short Percent Of Float | 0.4954 |
| Short Ratio | 7.79 |
| Source Interval | 15 |
| State | CA |
| Symbol | LENZ |
| Target High Price | 60.0 |
| Target Low Price | 20.0 |
| Target Mean Price | 41.14286 |
| Target Median Price | 39.0 |
| Total Cash | 292,347,008 |
| Total Cash Per Share | 9.324 |
| Total Debt | 815,000 |
| Total Revenue | 19,088,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.85 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 25.699724 |
| Two Hundred Day Average Change | -15.439724 |
| Two Hundred Day Average Change Percent | -0.60077393 |
| Type Disp | Equity |
| Volume | 120,064 |
| Website | https://www.lenz-tx.com |
| Zip | 92,075 |